Obesity drug Zepbound slashed risk of developing diabetes The FDA just approved semaglutide (specifically under the brand Wegovy who submitted the research for approval), for the treatment of Non Alcoholic Fatty Liver Disease, specifically Metabolic associated steatohepatitis (MASH). In combination Ozempic Face: Combat with Protein Secrets Checklist card Zepbound vs Mounjaro: What's the difference? Admired Wegovy Pill Weight Loss